Angiotech, Boston Scientific Win Dutch Patent Case

Law360, New York (January 17, 2007, 12:00 AM EST) -- Boston Scientific Corp. and Angiotech Pharmaceuticals Inc. won a key patent ruling Wednesday when a Dutch court barred rival Conor Medsystems Inc. from selling its drug-coated coronary stent in the Netherlands, just a day after an appeals court in London ordered the U.K. version of the patent at issue revoked.

The District Court in the Hague found that Conor Medsystems Inc.'s CoStar paclitaxel stent infringed one claim of the Dutch version of a European paclitaxel stent patent owned by Angiotech and licensed to Boston Scientific. The...
To view the full article, register now.